Comparison between three clotting assays for the detection of activated protein C linked to the presence of the factor V Leiden during pregnancy;Comparaison de trois reactifs pour la detection de la resistance g la puoteine C activee liee a la mutation du facteur V Leiden en cours de grossesse

Annales de Biologie Clinique

Volumn 56, Issue 4, 1998, Pages 445-450

  Magdelaine, A ^a   Soubrier, F ^a   Berkane, N ^a   Uzan, S ^a   Verdy, E ^a  

^a HÔPITAL TENON   (France)

Author keywords

APC resistance; Clothing assays; Factor V Leiden; Pregnancy

Indexed keywords

ACTIVATED PROTEIN C; ARGININE; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8; GLUTAMINE; REAGENT;

ACTIVATED PROTEIN C RESISTANCE; ARTICLE; BLOOD CLOTTING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DNA DETERMINATION; FEMALE; FETUS WASTAGE; GENE MUTATION; HETEROZYGOTE DETECTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; RISK; THROMBOEMBOLISM; ADULT; AGED; AMINO ACID SUBSTITUTION; ANALYTICAL EQUIPMENT; CHEMISTRY; COMPARATIVE STUDY; GENETICS; MIDDLE AGED; MISSENSE MUTATION; PREGNANCY COMPLICATION; THROMBOPHLEBITIS;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; FACTOR V; FEMALE; HUMANS; MIDDLE AGED; MUTATION, MISSENSE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; REAGENT KITS, DIAGNOSTIC; THROMBOPHLEBITIS;

EID: 0031668566     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C : Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993 ; 90 : 1004-8.
2. Koster T, Rosendaal FR, de Ronde F, Briêt E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor response to activated protein C : Leiden thrombophilia study. Lancet 1993 ; 342 : 1503-6.
3. Griffin JH, Evatt BL, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in a majority of thrombophilic patients. Blood 1993 ; 82 : 1989-93.
4. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994 ; 330 : 517-21.
5. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994 ; 369 : 64-7.
6. Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt BL. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 1994 ; 343 : 1362-3.
7. Vooberg J, Roelse J, Koopman R, et al. Association of idiopathic thromboembolism with single point mutation at Arg506 of factor V. Lancet 1994 ; 343 : 1535-6.
8. Zöller B, Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994 ; 343 : 1536-8.
9. Cook G, Walker ID, McCall F, Conkie A, Greer A. Familial thrombophilia and activated protein C resistance : thrombotic risk during pregnancy ? Br J Haematol 1994 ; 87 : 873-5.
10. Hellgren M, Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol 1995 ; 173 : 210-3.
11. Bokarewa MI, Bremme K, Blombäck M. Arg506Gln mutation in factor V and risk of thrombosis during pregnancy. Br J Haematol 1996 ; 92 : 473-8.
12. Dekker GA, de Vries JIP, Doelizsch PM, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995 ; 173 : 1042-8.
13. Preston FE, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996 ; 348 : 913-6.
14. Rai R, Regan L, Hadley E, Dave M, Cohen H. Second-trimester pregnancy loss is associated with activated protein C resistance. Br J Haematol 1996 ; 92 : 489-90.
15. Grisaru D, Fait G, Eldor A. Activated protein C resistance and pregnancy complications. Am J Obstet Gynecol 1996 ; 174 : 801-2.
16. Brenner B, Lanir N, Thaler I. Hellp syndrome associated with factor V R506Q mutation. Br J Haematol 1996 ; 92 : 999-1001.
17. Dizon-Townson DS, Nelson LM, Easton K, Ward K. The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996 ; 175 : 902-5.
18. Vasse M, Leduc O, Borg JY, Chretien MH, Montconduit M. Resistance to activated protein C: evaluation of three functional assay. Thrombosis Research 1994 ; 76 : 47-59.
19. Cumming AM, Tait RC, Fildes S, Yoong A, Keeney S, Hay RM. Development of resistance to activated protein C during pregnancy. Br J Haematol 1995 ; 90 : 725-7.
20. Mathonnet F, de Mazancourt P, Bastenaire B, et al. Activated protein C sensitivity ratio in pregnant women at delivery. Br J Haematol 1996 ; 92 : 244-6.
21. Bokarewa MI, Wramsby M, Bremme K, Blomback M. Variability of the response to activated protein C during pregnancy. Blood Coagul Fibrinolysis 1997 ; 8 : 239-44.
22. Cumming AM, Tait RC, Fildes S, Hay RM. Diagnosis of APC resistance during pregnancy. Br J Haematol 1996 ; 92 : 1026-7.
23. Alhenc-Gelas M, Aillaud MF, Bonvarlet MN, Dupuy G, Juhan-Vague I, Aiach M. Specificity of an assay based on a factor V-depleted plasma in patients carrying the Arg 506 Gln mutation. Thomb Haemost 1996 ; 75 : 976-7.
24. Tripodi A, Negri B, Bertina RM, Mannucci PR. Screening for the FV : Q506 mutation - Evaluation of thirteen plasma-based methods for their diagnosis efficacity in comparison with DNA analysis. Thromb Haemost 1997 ; 77 : 436-9.
25. Barbour LA, Pickard J. Controversies in thromboembolic disease during pregnancy : A critical review. Obst Gynecol 1995 ; 86 : 621-33.
26. Grandone E, Margaglione N, Colaizzo D, et al. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997 ; 77 : 822-4.
27. Mathonnet F, de Mazancourt P, Denninger MH, Morot M, Benattar N, Giudicelli Y. Role of factor VIII on activated protein C resistance ratio in inflammatory diseases. Br J Haematol 1996 ; 95 : 423-5.
28. Svensson PJ, Zöller B, Dahlbäck B. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls. Thromb Haemost 1997 ; 77 : 332-5.
29. Henkens CM, Bom VJJ, van der Meer J. Lowered APC-sensitivity ratio related to increased factor VIII-clotting activity. Thromb Haemost 1995 ; 74 : 1198-9.